Uriage Unveils Breakthrough Research on Triple Barrier Science at EADV 2026 in Vienna
In a significant development for dermatological science, Laboratoires Dermatologiques d'Uriage has revealed groundbreaking findings at the 2026 European Academy of Dermatology and Venereology (EADV) Congress in Vienna. The event showcased the latest research results emphasizing the relationship between skin barrier repair and microbiome improvement, crucial for combating prevalent skin conditions such as atopic dermatitis and acne.
Dr. Marius Anton Ionescu, MD, PhD, who serves as the Scientific Communication and Medical Director of Uriage, emphasized the essentiality of understanding immune mechanisms within the skin as the cornerstone of modern dermatology. 'Our presentations at EADV 2026 aim to provide dermatologists with clinically proven data that supports their prescriptions for common skin conditions,' Dr. Ionescu stated.
One of the key highlights is the introduction of XEMOSE C8+®, a pioneering product featuring biomimetic ceramides designed to enhance skin barrier function. This innovation is especially vital as atopic dermatitis affects approximately 20% of children and up to 10% of adults globally. The XEMOSE C8+® product works by restoring the natural quantity and diversity of ceramides, which are essential for maintaining a healthy skin barrier. Research indicates that patients using XEMOSE C8+® experience marked improvements, such as a reduction in symptoms like itching and dryness within just 24 hours of application.
In addition to XEMOSE C8+®, Uriage presented the BARIEDERM-CICA+® Repairing Cream. This product focuses on skin regeneration through a dual-action mechanism—creating an optimal environment for skin healing and regulating repair processes. Clinical evidence reveals that this cream significantly reduces issues related to skin scarring, showing a 90% improvement in redness and damaged skin appearance within days of use.
Moreover, Uriage shared findings on the BARIESUN® line, which leverages non-occlusive polymers to prevent the deep penetration of UV filters into the skin. This innovative strategy aims to enhance photoprotection, showcasing Uriage's commitment to cutting-edge skincare solutions.
Throughout these presentations, Uriage highlighted the importance of Uriage Repairing Thermal Water (URTW) as the foundational element of its product range. Rich in minerals and trace elements, URTW supports optimal hydration while reinforcing the skin’s physical and immune barriers. It symbolizes Uriage’s dedication to integrating scientific research into effective dermatological solutions.
Uriage also addressed the educational needs of dermatologists through the Uriage Pro platform, which offers a wealth of resources and an extensive dermatology atlas featuring over 12,000 clinical photographs.
Available in over 80 countries, Laboratoires Dermatologiques d'Uriage stands at the forefront of dermatological innovation. With more than 30 years of collaboration with dermatologists, the brand is committed to developing advanced dermocosmetics addressing various skin disorders. Uriage continues to work with a global Scientific Advisory Board, further enhancing its reputation as a leader in dermatological science.
For professionals attending the EADV Congress, Uriage invites you to visit Booth 546 (Hall 5, Level 0) for detailed interactions and insights into their revolutionary products and pioneering research.
Dr. Marius Anton Ionescu, MD, PhD, who serves as the Scientific Communication and Medical Director of Uriage, emphasized the essentiality of understanding immune mechanisms within the skin as the cornerstone of modern dermatology. 'Our presentations at EADV 2026 aim to provide dermatologists with clinically proven data that supports their prescriptions for common skin conditions,' Dr. Ionescu stated.
One of the key highlights is the introduction of XEMOSE C8+®, a pioneering product featuring biomimetic ceramides designed to enhance skin barrier function. This innovation is especially vital as atopic dermatitis affects approximately 20% of children and up to 10% of adults globally. The XEMOSE C8+® product works by restoring the natural quantity and diversity of ceramides, which are essential for maintaining a healthy skin barrier. Research indicates that patients using XEMOSE C8+® experience marked improvements, such as a reduction in symptoms like itching and dryness within just 24 hours of application.
In addition to XEMOSE C8+®, Uriage presented the BARIEDERM-CICA+® Repairing Cream. This product focuses on skin regeneration through a dual-action mechanism—creating an optimal environment for skin healing and regulating repair processes. Clinical evidence reveals that this cream significantly reduces issues related to skin scarring, showing a 90% improvement in redness and damaged skin appearance within days of use.
Moreover, Uriage shared findings on the BARIESUN® line, which leverages non-occlusive polymers to prevent the deep penetration of UV filters into the skin. This innovative strategy aims to enhance photoprotection, showcasing Uriage's commitment to cutting-edge skincare solutions.
Throughout these presentations, Uriage highlighted the importance of Uriage Repairing Thermal Water (URTW) as the foundational element of its product range. Rich in minerals and trace elements, URTW supports optimal hydration while reinforcing the skin’s physical and immune barriers. It symbolizes Uriage’s dedication to integrating scientific research into effective dermatological solutions.
Uriage also addressed the educational needs of dermatologists through the Uriage Pro platform, which offers a wealth of resources and an extensive dermatology atlas featuring over 12,000 clinical photographs.
Available in over 80 countries, Laboratoires Dermatologiques d'Uriage stands at the forefront of dermatological innovation. With more than 30 years of collaboration with dermatologists, the brand is committed to developing advanced dermocosmetics addressing various skin disorders. Uriage continues to work with a global Scientific Advisory Board, further enhancing its reputation as a leader in dermatological science.
For professionals attending the EADV Congress, Uriage invites you to visit Booth 546 (Hall 5, Level 0) for detailed interactions and insights into their revolutionary products and pioneering research.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.